Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
11.16
+0.16 (1.45%)
Nov 20, 2024, 4:00 PM EST - Market closed
Cybin Employees
Cybin had 50 employees as of March 31, 2024. The number of employees did not change compared to the previous year.
Employees
50
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,831,185
Market Cap
227.14M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 50 | 0 | - |
| Mar 31, 2023 | 50 | 0 | - |
| Mar 31, 2022 | 50 | 12 | 31.58% |
| Mar 31, 2021 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ModivCare | 21,200 |
| Aurora Cannabis | 1,073 |
| Inogen | 834 |
| Lifecore Biomedical | 524 |
| SOPHiA GENETICS | 430 |
| Sutro Biopharma | 302 |
| LifeMD | 211 |
| TScan Therapeutics | 154 |
CYBN News
- 3 days ago - Cybin Reports Positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder - Business Wire
- 7 days ago - Cybin to Present 12-Month Phase 2 Data for CYB003 in Major Depressive Disorder on November 18, 2024 - Business Wire
- 8 days ago - Cybin Initiates PARADIGM: A Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder and Reports Second Quarter Financial Results - Business Wire
- 21 days ago - Cybin to Participate at the 2024 Milken Institute Future of Health Summit - Business Wire
- 4 weeks ago - Cybin Announces Grant of First U.S. Composition of Matter Patent in Support of its CYB005 Phenethylamines Program - Business Wire
- 4 weeks ago - Undercovered Dozen: Endava, Cross Country Healthcare, Cybin, Equinor + - Seeking Alpha
- 5 weeks ago - Cybin: Top Value Psychedelic Stock - Seeking Alpha
- 7 weeks ago - Cybin to Participate in Water Tower Research Fireside Chat on October 8, 2024 - Business Wire